Artificial intelligence for diagnosing pattern hair loss
Part of Skin clinical trials.
This study uses artificial intelligence to help diagnose pattern hair loss (also called androgenetic alopecia) from scalp images. It may help doctors identify the condition more accurately and is testing the AI tool on different types of patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 to 50 years old
- You have been diagnosed with or suspect you have pattern hair loss (male or female pattern baldness)
- Hair loss was confirmed by a special scalp examination (called trichoscopy)
- You do not have other scalp conditions like psoriasis, seborrheic dermatitis, or scarring hair loss
- If you are a healthy volunteer without pattern hair loss, you may also participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses artificial intelligence to help diagnose seborrheic keratosis, a common harmless skin growth. It aims to see if the AI can accurately identify these growths from skin samples, which could help doctors make faster and more reliable diagnoses.
This study is testing whether an artificial intelligence (AI) system can accurately diagnose basal cell carcinoma, a common type of skin cancer, from microscope slide images. If you have had a biopsy slide of a skin lesion that was already diagnosed as basal cell carcinoma, your sample might be used to help train or test the AI.
This study uses artificial intelligence (AI) to look at skin biopsy slides from people with mycosis fungoides, a type of skin lymphoma. The goal is to see if AI can help doctors diagnose this condition more accurately, which could lead to better and earlier treatment.
This study uses artificial intelligence to analyze magnified skin images of basal cell carcinoma to predict the cancer's subtype and risk classification. It aims to improve diagnosis and treatment planning without additional procedures.
This trial tests an artificial intelligence (AI) system that helps doctors decide if a skin lesion might be cancer. If you are seeing your primary care doctor about a mole or spot that concerns them or you, this study might be for you.
This study tests how well an AI system can diagnose retinal diseases from eye photos. It might help if you need a quick and accurate diagnosis using standard eye imaging.
Hear when a new Androgenetic Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.